Profile Core value Main business Legitimacy Social Responsibility
    Patents Research Direction Technology Strength
  API Intermediates Side chain for Paclitaxel and Docetaxel N-1 stage
  Production management QC Quality System branch factory
 
logn  

username:

 password:

 

  home
 
  Products Center
  API
Paclitaxel (Semi-synthetic)
Paclitaxel (Natural)
Docetaxel Anhydrous
Docetaxel Trihydrate
Cabazitaxel
Irinotecan HCl Trihydrate 99.5%
Entecavir
Carboplatin
Oxaliplatin
Cisplatin
Etoposide USP31
Palonosetron Hydrochloride
Capecitabine
Methotrexate
Pemetrexed disodium hydrate
Pemetrexed disodium hepthydrate
  N-1 stage of Paclitaxel and Docetaxel
7-Troc-Paclitaxel
7,10-di-Troc-Docetaxel
more...
  Main Intermediates
10-Deacetylbaccatin III
Baccatin III
more...
  Side chain for Paclixel semi-Synthetic
(4S,5R)-3-(N-benzoyl)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid
  Side chain of Docetaxel
(4S,5R)-3-(N-tert-butoxycarbony)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid
  Side chain for Paclitaxel and Docetaxel
(3R,4S)-3-hydroxy-4-phenyl-2-azetidinone
Ethyl (2R,3S)-3-Phenylisoserine Ester
more...
Your location >>Home>>About us>>profile
 
 
Shanghai Jinhe Bio-Pharmaceutical Co., Ltd. (Former name: Shanghai Jinhe Bio-Technology Co.,Ltd.) is a high Bio-Tech private enterprise dedicated to R&D, manufacturing and marketing anti-cancer APIs and their intermediates.

Jinhe was established in March 2002. Based on the R&D achievement of FUDAN university, at the beginning it launched the international business of processing Paclitaxel API. After severalyears of development, we has been emerging as the largest processor on Taxus biomass in China. Afterwards, we successfully developed Docetaxel Anhydrous( Trihydrate), Irinotecan HCl Trihydrate, Etoposide and other products, developing Anti-cancer products from nature extracting to semi-synthetical Anti-cancer products. In recent two years we additionally developed Cabazitaxel, Palonosetron Hydrochloride and so on, developed Anti-cancer from botanical raw materials to Anti-cancer drug.

Since its establishment, we have been positioning our core value as specialization, aiming to go for internationalization, striving to cultivate own core competitiveness.  Especially in respect of the effective use of Yew biomass and of the extraction, purification, synthesization of its active components. Jinhe has been in leading position and in possession of its own independent patented technique.

Our main products include Paclitaxel, Docetaxel Anhydrous (Trihydrous),Cabazitaxel, Irinotecan HCl Trihydrate, Etoposide, Palonosetron Hydrochloride, 10 DAB III, Podophyllotoxin etc. These products are mainly used for Anti-cancer drugs production, with a view to benefit the numerous cancer patients.

   
CopyRight(C)2006,Shanghai Jinhe Bio-Pharmaceutical Co.,Ltd. All Rights Reserved. Supported by ChemNet ChinaChemNet Toocle Copyright Notice ChemNet
HOME About us Products R & D Production and QA Contact us CHINESE
Ǯ